Saxenda vs Semaglutide: Comparing First- and Second-Generation GLP-1 Drugs

You have been on Koh Samui long enough to settle into a routine. The scooter is parked outside the villa, the beach walks are daily, and somewhere between the pad thai and the sunsets over Lamai, the question of weight management comes back around. Maybe you have been on Saxenda for a while and heard that semaglutide delivers better results. Maybe you are starting fresh and want to know which drug makes sense before sitting down with a doctor.

These are two different generations of the same drug class. Both work on the same receptor. They are not interchangeable, and the decision involves more than picking whichever one sounds newer. What follows covers the clinical evidence, the practical differences, who should still consider liraglutide, and what getting a GLP-1 prescription actually looks like on Koh Samui.

How Liraglutide and Semaglutide Actually Work

Both drugs are GLP-1 receptor agonists. GLP-1 is a hormone your gut releases after you eat. It tells your brain you are full, slows how fast food moves through your stomach, and helps regulate blood sugar. Both drugs mimic this hormone, but they stay active for very different lengths of time.

Liraglutide has a half-life of roughly 13 hours. That is why it needs a daily injection to keep working. Semaglutide has been chemically modified to bind to a blood protein called albumin, which extends how long it stays active to approximately one week. That structural difference explains the once-weekly dosing schedule.

This is not just a convenience gap. More consistent drug levels across the week means more consistent appetite suppression, which is partly why semaglutide’s efficacy numbers are higher.

What the Clinical Evidence Shows for Saxenda Liraglutide vs Semaglutide

The STEP 8 trial, published in JAMA in 2022, is the only head-to-head randomised controlled trial comparing these two drugs directly. Participants without type 2 diabetes received either semaglutide 2.4 mg weekly or liraglutide 3.0 mg daily over 68 weeks. Semaglutide produced a mean body weight reduction of 15.8% versus 6.4% with liraglutide.

In practical terms, for someone weighing 90 kg, that is roughly 14 kg lost with semaglutide versus roughly 6 kg with liraglutide. Semaglutide also had a higher proportion of patients reaching clinically meaningful weight loss. Discontinuation due to adverse events was lower with semaglutide than liraglutide in the trial (3.2% versus 12.6%).

Beyond weight, semaglutide has cardiovascular outcome data from the SELECT trial, which showed a reduction in major cardiovascular events in adults with obesity and existing heart disease. Liraglutide has separate cardiovascular data from the LEADER trial, conducted in patients with type 2 diabetes. The two trial populations differ, so the results cannot be compared directly, but cardiovascular benefit is worth discussing with your doctor if you have a history of heart disease.

Dosing, Titration, and What to Expect

Saxenda reaches its full dose in about five weeks. Semaglutide’s titration is slower, which is designed to reduce the nausea that peaks early in treatment. Some patients find the longer ramp-up of semaglutide easier to tolerate than the quicker escalation of liraglutide.

Side Effects and Tolerability

The side effect profile of the two drugs is broadly similar. Nausea, vomiting, constipation, and injection site reactions are common to both. These tend to be most pronounced during dose escalation and often ease once you reach your maintenance dose.

The STEP 8 trial showed that discontinuation due to adverse events was lower with semaglutide (3.2%) than with liraglutide (12.6%). Individual response still varies. Some patients genuinely tolerate one better than the other, and that matters when choosing or switching.

Pancreatitis is a rare but serious risk with both drugs. If you develop severe, persistent upper abdominal pain on either medication, stop it and see a doctor. Both drugs are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2.

Who Should Still Choose Saxenda

Semaglutide has better headline efficacy. But liraglutide is not obsolete, and there are clear situations where it remains the right choice.

If you had significant nausea or GI side effects on semaglutide and had to stop, liraglutide is worth trying as a tolerated alternative. Daily dosing also gives more flexibility during titration if fine adjustments are needed. Saxenda is approved for adolescents aged 12 and above for weight management in the US and EU. Wegovy was also approved by the FDA for adolescents aged 12 and above in December 2022, so the adolescent approval gap between the two drugs has narrowed. Availability of either drug for adolescents varies by country, and local prescribing rules apply. In some countries, liraglutide is also substantially cheaper than branded semaglutide, making it the only realistic option for patients on a limited budget.

If you are stable and doing well on Saxenda, switching purely to chase better average trial numbers may not serve you. Individual response matters more than population averages.

Switching from Saxenda to Semaglutide

Because liraglutide clears the body relatively quickly, no formal washout period is needed before starting semaglutide. You stop liraglutide and begin semaglutide at its lowest starting dose. You do not jump to the dose that feels equivalent to where you were with Saxenda. The titration schedule starts from the beginning, every time.

Skipping re-titration is the main reason patients experience severe nausea when switching. The ramp-up with semaglutide runs about 16 weeks. Plan for that, and do not expect results at the same pace as before.

If you are considering this switch while staying on Koh Samui, Doctor Samui can review your history, check your candidacy, and manage the transition properly rather than leaving you to work out dosing alone.

Getting GLP-1 Treatment on Koh Samui

GLP-1 medications are prescription drugs in Thailand. You cannot source them without a valid prescription from a licensed physician.

This matters particularly here because compounded and counterfeit semaglutide products circulate online and through non-medical channels in Thailand. Dosing in compounded products is often unreliable. Sterility is not guaranteed. The risks are real: incorrect dosing, infection at the injection site, and unknown ingredients. If you are buying GLP-1 products online in Thailand without a prescription, you are taking a genuine clinical risk.

Doctor Samui offers GLP-1 consultations at the Chaweng clinic. The clinic can assess your suitability for liraglutide or semaglutide, review contraindications, and provide a legitimate prescription for authorised products. For long-stay expats in areas like Maenam or Bophut, mobile doctor services are also available across the island for follow-up care without the drive to Chaweng each time.

You can read more about the first- and second-generation GLP-1 drugs available through the clinic at Doctor Samui. For a broader picture of your health before starting any weight management treatment, a health check-up in Koh Samui gives your doctor the baseline information needed to prescribe safely.